The fourth EU Health Programme (2021-2027), managed by the European Health and Digital Executive Agency (HADEA), is the main instrument the European Commission uses to implement the EU Health Strategy. The EU4health programme represents an ambitious response to the COVID-19 pandemic, but goes beyond crisis response to address the resilience of European healthcare systems.
The programme has 4 overarching goals. It aims to:
- Improve and foster health in the European Union;
- Tackle cross-border health threats;
- Improve medicinal products, medicinal devices and crisis-relevant products;
- Strengthen health systems, their resilience and resource efficiency.
The EU4Health Programme will also be investing in urgent health priorities, namely the:
- Response to COVID-19 pandemic, and resilience for cross-border health threats;
- Europe’s Beating Cancer Plan;
- Pharmaceutical Strategy for Europe.
EU4Health is implemented through annual work programmes.
For various types of organisations, including universities.
Research groups from universities can submit a project proposal as a coordinator (of the consortium) or participate as another beneficiary (consortium partner).
Duration and budget
Projects have in principle a duration of no more than 3 years.
The EU-contribution covers in principle only a part of the eligible costs (usually 60%). In case of exceptional utility up to 80% can be granted.
Interested researchers should timely contact the Grants Office of Research, Innovation & Valorisation Antwerp (RIVA) to discuss co-funding arrangements and to get clearance.
Proposals are submitted through the EU Funding and Tenders Portal.
More information about the EU4Health Programme and an overview of the calls can be found on the website of HADEA and on the EU Funding and Tenders Portal.